Reversible cardiogenic shock following 5-fluorouracil infusion.
5-Fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.
Ferté
Charles
C
Phase I unit (SITEP), Department of Medicine, Institut Gustave Roussy, 94805, Villejuif, France. chferte@hotmail.com
Gomez Roca
Carlos
C
Loriot
Yohann
Y
Bahleda
Rastislav
R
Moldovan
Cristian
C
Cohen
Ariel
A
Izzedine
Hassan
H
Soria
Jean-Charles
JC
Ederhy
Stephane
S
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012770:Shock, Cardiogenic / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil